新闻
2026-11-19
引进/卖出
2026-11-19
Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)
临床结果上市批准
2026-11-19
并购
2026-11-19
NeuroGenesis Bio Receives FDA Clearance to Proceed with Expanded Access Program for NG01 in Progressive Multiple Sclerosis
细胞疗法临床结果
2026-11-18
Carnyx Therapeutics Unveils Oral Sleep Candidate CNYX-005 with Preclinical Data Showing Increased NREM Sleep
临床结果
融资
2026-11-18
并购引进/卖出
2026-11-18
Acadia Pharmaceuticals Presents Additional Phase 2 RADIANT Study Results Evaluating Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis at the 2026 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
临床结果
Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
临床结果上市批准孤儿药
2026-11-17
FDA OKs third renal indication for Roche's Gazyva, this time primary membranous nephropathy
临床结果上市批准优先审批突破性疗法